Citadel Advisors »

Amicus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $29k 9.3k 3.13

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
Jpmorgan Chase & Co
Wellington Management Company
Redmile Group
William Blair Investment Management
Henderson Group
Palo Alto Investors
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
Artal Group
Bank of America Corporation
Norges Bank Investment Management
Blackstone Group

View all funds holding Amicus Therapeutics